The literature review in this article and network analysis suggests ORMDL3 as a potential therapeutic target, however, in-depth research on the role of ORMDL3 in IBD and designing novel molecules to target ORMDL3 should be the focus of future investigations. This evidence concerns the gene ORMDL3 and inflammatory bowel disease.